sábado, 10 de marzo de 2018

Press Announcements > FDA authorizes, with special controls, direct-to-consumer test that reports three mutations in the BRCA breast cancer genes

Press Announcements > FDA authorizes, with special controls, direct-to-consumer test that reports three mutations in the BRCA breast cancer genes



FDA authorizes, with special controls, direct-to-consumer test that reports three mutations in the BRCA breast cancer genes

Test only reports 3 out of more than 1,000 known BRCA mutations and negative result doesn’t rule out increased cancer risk

No hay comentarios: